Search
Integra Lifesciences Holdings Corp
IARTAdd to Watchlist
16.650USD
-0.470-2.75%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.29BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Integra Lifesciences Holdings Corp is 6.60, ranking 166 out of 199 in the Healthcare Equipment & Supplies industry. The average price target is 13.00, with a high of 25.00 and a low of 10.00.
Analyst Rating
Based on
12
analysts
Hold
Current Rating
20.000
Target Price
+20.12%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Integra Lifesciences Holdings Corp
IART
12
Medtronic PLC
MDT
34
Stryker Corp
SYK
32
Dexcom Inc
DXCM
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
29
1
2
3
...
22
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Integra Lifesciences Holdings Corp's expected revenue for the next quarter?
Integra Lifesciences Holdings Corp's expected revenue is 416.60M.
What is Integra Lifesciences Holdings Corp's price target?
Analysts forecast that Integra Lifesciences Holdings Corp's price target is USD 13.00, with the highest forecast at USD 25.00 and the lowest forecast at USD 10.00.
How have Integra Lifesciences Holdings CorpIART's recent earnings per share performed?
The market expectation was USD 0.06, while Integra Lifesciences Holdings CorpIART's earnings per share (EPS) for the previous quarter was USD -0.06. EPS for the next quarter is expected at USD 0.56.
What is the analyst rating for Integra Lifesciences Holdings Corp?
Based on the ratings of Integra Lifesciences Holdings Corp's stock from 12 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.